1. Home
  2. XNCR vs CLNE Comparison

XNCR vs CLNE Comparison

Compare XNCR & CLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • CLNE
  • Stock Information
  • Founded
  • XNCR 1997
  • CLNE 2001
  • Country
  • XNCR United States
  • CLNE United States
  • Employees
  • XNCR N/A
  • CLNE N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • CLNE Natural Gas Distribution
  • Sector
  • XNCR Health Care
  • CLNE Utilities
  • Exchange
  • XNCR Nasdaq
  • CLNE Nasdaq
  • Market Cap
  • XNCR 547.8M
  • CLNE 448.6M
  • IPO Year
  • XNCR 2013
  • CLNE 2007
  • Fundamental
  • Price
  • XNCR $8.62
  • CLNE $2.46
  • Analyst Decision
  • XNCR Buy
  • CLNE Strong Buy
  • Analyst Count
  • XNCR 10
  • CLNE 5
  • Target Price
  • XNCR $23.33
  • CLNE $3.59
  • AVG Volume (30 Days)
  • XNCR 726.1K
  • CLNE 1.5M
  • Earning Date
  • XNCR 11-05-2025
  • CLNE 11-05-2025
  • Dividend Yield
  • XNCR N/A
  • CLNE N/A
  • EPS Growth
  • XNCR N/A
  • CLNE N/A
  • EPS
  • XNCR N/A
  • CLNE N/A
  • Revenue
  • XNCR $146,929,000.00
  • CLNE $420,579,000.00
  • Revenue This Year
  • XNCR $22.06
  • CLNE $1.46
  • Revenue Next Year
  • XNCR N/A
  • CLNE $2.46
  • P/E Ratio
  • XNCR N/A
  • CLNE N/A
  • Revenue Growth
  • XNCR N/A
  • CLNE 4.08
  • 52 Week Low
  • XNCR $6.92
  • CLNE $1.30
  • 52 Week High
  • XNCR $27.24
  • CLNE $3.67
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 55.91
  • CLNE 51.27
  • Support Level
  • XNCR $8.25
  • CLNE $2.41
  • Resistance Level
  • XNCR $8.73
  • CLNE $2.61
  • Average True Range (ATR)
  • XNCR 0.37
  • CLNE 0.10
  • MACD
  • XNCR 0.06
  • CLNE -0.02
  • Stochastic Oscillator
  • XNCR 69.03
  • CLNE 12.07

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.

Share on Social Networks: